AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Ordeglim-Duo 2/500 Tablet SR

Prescription Icon
Prescription Required

Marketer

Osiante Biotech

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Ordeglim-Duo 2/500 Tablet SR

Diabexe-Comb 2/500 Extended-Release tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by managing blood glucose levels. Diabexe-Comb 2/500 ER should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may adjust based on your blood sugar response. Continued use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision loss, neuropathy, and limb damage. Remember, this medication complements a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. The most frequent adverse effect is hypoglycemia (low blood sugar). Learn to recognize symptoms like sweating, dizziness, headache, and tremors, and know how to counteract them. Regular meals and carrying a rapid-acting glucose source (e.g., sugary sweets or juice) are vital preventative measures. Alcohol consumption elevates hypoglycemia risk and should be limited. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Its suitability for pregnant or lactating women requires medical consultation. Regular blood glucose monitoring is essential, and your doctor may order blood tests to track blood cell counts and liver function.

Uses of Ordeglim-Duo 2/500 Tablet SR

Managing type 2 diabetes

Major Benefits of Ordeglim-Duo 2/500 Tablet SR:

Follow your doctor's instructions precisely regarding the dosage and treatment length for Ordeglim-Duo 2/500 Tablet SR. Ingest the tablet whole; do not crush, chew, or break it. Administer this medication with food.

Common Side effects of Ordeglim-Duo 2/500 Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Ordeglim-Duo 2/500 Tablet SR:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and timeframe. Ingest the entire tablet without chewing, crushing, or fracturing. It's recommended to take Ordeglim-Duo 2/500 SR tablets with a meal.

How Ordeglim-Duo 2/500 Tablet SR works:

Ordeglim-Duo 2/500 SR tablets contain glimepiride and metformin, two medications used to manage diabetes. Glimepiride, a sulfonylurea, stimulates the pancreas to release more insulin, thus reducing blood sugar. Metformin, a biguanide, acts by decreasing liver glucose production, slowing intestinal glucose absorption, and enhancing the body's response to insulin.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Ordeglim-Duo 2/500 SR tablets with alcohol is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Ordeglim-Duo 2/500 SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against any risks prior to prescribing this medication. Seek medical advice before taking this medicine.

Breast feedingBreast feedingUNSAFE

Extended-release Ordeglim-Duo 2/500 tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant harm from the medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Ordeglim-Duo 2/500 SR tablets cautiously, potentially requiring dosage modification. Consult your physician for guidance. Ordeglim-Duo 2/500 SR tablets are contraindicated in patients with severe kidney disease. Regular monitoring of kidney function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Ordeglim-Duo 2/500 Tablet SR cautiously, potentially requiring dosage modification. A physician's consultation is recommended. For individuals with mild to moderate liver disease, Ordeglim-Duo 2/500 Tablet SR is typically initiated at a reduced dosage; however, its use is contraindicated in those with severe hepatic dysfunction.

What if you forget to take Ordeglim-Duo 2/500 Tablet SR :

Should you forget to take your Ordeglim-Duo 2/500 Tablet SR, administer it immediately upon remembrance. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take more than the prescribed amount.

Facts to Know About Ordeglim-Duo 2/500 Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Ordeglim-Duo 2/500 Tablet SR

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Ordeglim-Duo 2/500 Tablet SR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare but dangerous side effect is particularly risky for patients with kidney disease, the elderly, or those who consume significant amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these symptoms, discontinue Ordeglim-Duo 2/500 Tablet SR immediately and seek urgent medical attention.
Ordeglim-Duo 2/500 SR tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It is not suitable for type 1 diabetes.
Ordeglim-Duo 2/500 SR tablets may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged Ordeglim-Duo 2/500 Tablet SR use can lead to vitamin B12 deficiency by impairing its absorption. This deficiency, if left untreated, may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and ataxia), urinary issues, and cognitive changes. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Ordeglim-Duo 2/500 SR Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Ordeglim-Duo 2/500 SR tablets with alcohol is unsafe. This combination can dangerously lower blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Ordeglim-Duo 2/500 Tablet...
41
MRP 50
18% off